13th International Cancer and Medical Oncology Conference & Exhibition

Name: 13th International Cancer and Medical Oncology Conference & Exhibition
Start: 2027-02-01T08:00
End: 2027-02-02T18:00
Location: Novotel Al Barsha

CancerUCG

2027-02-01 – 2027-02-02 · Novotel Al Barsha · DUBAI · UAE · Hybrid · 30 CME/CPD Credits by The ACCME CME

Advancing Cancer Research, Diagnostics, and Precision Oncology

Speakers

Dr. Abdulaziz Alomiery — Assistant Professor at the Basic Science Department, King Saud University
Dr. Advait Ajit Karmarkar — First Year Resident, Dept of Pathology, Dr DY Patil Medical College
Dr. Ahmed Yehia Sharab — Distinguished Physician, Co-Founder and CEO, HCMA AI
Dr. Aisha Memon — Assistant Professor and a Consultant Histopathologist, Aga Khan University Hospital, Karachi, Pakistan
Dr. Aishwarya Thakurdesai — MBBS from Seth G. S. Medical College in Mumbai, Garnered Several Awards and Honors, Including the 2024 AASLD Foundation Emerging Liver Scholar Award
Dr. Akanksha Anu — Advances in Thyroid Pathology
Dr. Akanksha Pandey — Department of Pathology, Heritage Institute of Medical Sciences, Varanasi
Dr. Aliyarbayova Aygun Aliyar — Assistant professor of Department of Cytology, embryology and Histology, Azerbaijan Medical University
Dr. Ashwini Malla — Assistant Professor, PSG College of Arts and Science
Dr. Babatope Lanre Awosusi — Head of the Histopathology Department, King Khalid General Hospital, Al Majmaah
Dr. Bangkang Fu — Research primarily focuses on cardiovascular, neurological, and oncological imaging, Guizhou University
Dr. Batool Ahmad — Pathology Resident, LN Medical College and J.K. Hospital
Dr. Emil Salmo — Consultant Pathologist, Department of Histopathology, The Royal Oldham Hopspita
Dr. Eshraq El Masry — DHA-licensed Clinical Oncologist and General Practitioner based in the UAE
Dr. Esraa Aldujaily — Head of the Department of Pathology and Forensic Medicine, University of Kufa/ Faculty of Medicine
Dr. Folinas Konstantinos — Consultant Medical Oncologist, Oncology Department of 251 Airforce General Hospital
Dr. Gurbanova Shahana Gazanfar — Assistant of Department of Cytology, Embryology and Histology, Azerbaijan Medical University
Dr. Hadassah Sade — Managing Director at AstraZeneca Computational Pathology, AstraZeneca
Dr. Iskander Chaudhry — Consultant Pathologist, Royal Blackburn Teaching Hospital
Dr. Jose Manuel Cervera-Grau — Medical Oncology (18ys) INCLIVA in Spain, International Cancer Care Society
Dr. Juliana Bicca — Speaker, Vice-President of the Brazilian Academy of Functional and Integrative Medicine
Dr. Khalid Al-Baimani — Medical Oncologist
Dr. Khan Ummiya Afreen — Department of Pathology, Kamineni Academy Of Medical Sciences And Research Center
Dr. Leon Wreyford — Oncologist Communication / Health Professional, University of Southern Queensland
Dr. Maria Putova — Biologist-Researcher in Clinical Laboratory Diagnostics, Moscow Clinical Scientific Center
Dr. Matus Coma — Leading scientist at the Department of Pharmacology, Medical Faculty, Pavol Jozef Safarik University
Dr Meg Rynderman OAM — Australian Cancer Survivorship Centre at Peter, Consumer Advocate - Australian Cancer Survivorship Centre at Peter MacCallum Cancer Centre
Dr. Mehrdad Mohammadi — Assistant Professor SUMS and chief executive officer, Smart Medical Centre
Dr. Nada Shamina — Chemical Pathologist in the UK
Dr. Nariman Nawar — Pathologyist, West Virginia University | WVU · Department of Pathology MD
Dr. Neha Kamble — President- Medicare Charitable Trust Foundation, Dr. D.Y. Patil Medical College
Dr Neha Patel — CONSULTANT RADIATION ONCOLOGIST, ADDITIONAL MEDICAL DIRECTOR
Dr. Noskova Karina — Head of the Laboratory, Moscow Clinical Scientific Center
Dr. Pradeep Kumar Kar — Kidwai Memorial Institute of Oncology, Fortis Cancer Institute and Farcast Biosciences
Dr. Samira Yagubova — Associate professor, Department of Pathology, Azerbaijan Medical University
Dr Sanya Arora — Oncology Fellow, The London Clinic,, Clinical research fellow, ULCH,
Dr. Shahla Masood — Professor and Chair, Department of Pathology and Laboratory Medicine, University of Florida College of Medicine – Jacksonville
Dr. Shraddha Krupa — Pathology Resident
Dr. Silky Rai — Department of Oncopathology, Mahamana Pandit Madan Mohan Malviya Cancer Centre
Dr. Sviatoslav Zinovev — Oncologist, Nizhny Novgorod Research Institute of Oncology
Dr. Syeda Ayesha Fatima — Assistant Professor, Department of Pharmacology, Sulaiman Al Rajhi University
Dr. Tadeja Skok — Breast Cancer, Imaging Characteristics in Breast Cancer
Dr. Voropaeva Yana — Physician of Clinical laboratory diagnostics, Moscow Clinical Scientific Center
Dr. Wardah Fatima — Oral Pathology resident at Ziauddin University, Karachi, Can Saliva Replace Tissue? The Role of Liquid Biopsy and AI in Oral Oncology
Dr. Weam Mohamed Ahmed Eltoum — Consultant Histopathologist, Stockport NHS Foundation Trust
Eléonore DJIKEUSSI — Founder, Oncologist–Hematologist & Nutrition Expert, NutriGnosis SA
Mr. Alexandre Mendes — Cardio-Oncology & Patient Safety
Mr. Omar Ali — Former NICE adviser and head of payers at Verpora
Mr. Salam Musa — Consultant Oncoplastic breast surgeon, Presentation Focus: Impact of Breast Surgery on Patients
Mrs. Uta Rouse Bsc — VE-comedus UG™, Hospizinitiative Rostock e.V.
Ms. Ginny Dent Brant — Cancer Survivor, Holistic Healing Approaches &amp;amp; Cancer Survivorship
Ms. Rania Mohamad Othman, Al-Sham Private University
Prof. Nadia Sam — Laboratory of language, University of Blida2 Lounici-Algeria

Tracks

Track 1-Cancer: **[Cancer](https://cancer.ucgconferences.com/submit-abstract)** is a complex group of diseases marked by the uncontrolled growth of abnormal cells, which can invade nearby tissues and spread to distan
Track 2: Medical Oncology: **[Medical Oncology](https://cancer.ucgconferences.com/submit-abstract)** is a specialized field focused on the prevention, diagnosis, and treatment of cancer through systemic therapies such as chemot
Track 3:Immunotherapy: **[Immunotherapy](https://cancer.ucgconferences.com/submit-abstract)** is an innovative approach to cancer treatment that harnesses and strengthens the body’s immune system to recognize and fight canc
Track 4: Radiotherapy: **[Radiotherapy](https://cancer.ucgconferences.com/submit-abstract)**, also known as radiation therapy, is a widely used cancer treatment that employs high-energy radiation to destroy cancer cells or
Track 5: Chemotherapy: **[Chemotherapy](https://cancer.ucgconferences.com/submit-abstract)** is a widely used cancer treatment that employs powerful drugs to destroy cancer cells or slow their growth and division. Because t
Track 6: Surgical Oncology: **[Surgical Oncology](https://cancer.ucgconferences.com/submit-abstract)** is a specialized field of medicine focused on the surgical diagnosis, staging, and treatment of cancer. Surgical oncologists
Track 7: Hormone-therapy: **[Hormone Therapy](https://cancer.ucgconferences.com/submit-abstract)** is a treatment approach that uses hormones or hormone-blocking medications to manage hormone-related conditions and diseases. I
Track 8: Leukemia: **[Leukemia](https://cancer.ucgconferences.com/submit-abstract)** is a type of cancer that affects the blood and bone marrow, which is the soft, spongy tissue inside bones where blood cells are produc
Track 9: Cancer Genetics: ** [Cancer genetics](https://cancer.ucgconferences.com/submit-abstract)** is the study of genetic mutations and alterations that drive the initiation, progression, and metastasis of cancer. It focuses
Track 10: Cancer Epigenetics: **[Cancer Epigenetics](https://cancer.ucgconferences.com/submit-abstract)** explores heritable changes in gene expression that occur without altering the underlying DNA sequence. These epigenetic chan
Track 11: Tumor Microenvironment: The **[Tumor Microenvironment](https://cancer.ucgconferences.com/submit-abstract)** (TME) is the complex and dynamic environment surrounding a tumor, consisting of immune cells, stromal cells, blood v
Track 12: Cancer Metastasis: **[Cancer metastasis](https://cancer.ucgconferences.com/submit-abstract)** is the complex process through which cancer cells detach from the primary tumor, invade surrounding tissues, and spread to di
Track 13: Breast cancer: **[Breast cancer](https://cancer.ucgconferences.com/submit-abstract)** is a major form of cancer that develops when abnormal cells in the breast tissue grow and divide uncontrollably, potentially form
Track 14: Lung Cancer: **[Lung cancer](https://cancer.ucgconferences.com/submit-abstract)** is a serious malignancy that originates in the tissues of the lungs and is characterized by the uncontrolled growth of abnormal cel
Track 15: Colorectal Cancer: **[Colorectal cancer](https://cancer.ucgconferences.com/submit-abstract)** is a common malignancy that develops in the colon or rectum, which are integral parts of the digestive system. It often begin
Track 16: Prostate Cancer: **[Prostate cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that originates in the prostate gland, a small gland in the male reproductive system that contributes to the pr
Track 17: Skin Cancer: **[Skin cancer](https://cancer.ucgconferences.com/submit-abstract)** is a group of malignancies characterized by the uncontrolled growth of abnormal cells in the skin. Prolonged exposure to ultraviole
Track 18: Blood Cancer: **[Blood cancer](https://cancer.ucgconferences.com/submit-abstract)**, or hematologic malignancy, affects the blood, bone marrow, and lymphatic system, causing abnormal production and function of bloo
Track 19: Brain Tumor: **[Brain tumors](https://cancer.ucgconferences.com/submit-abstract)** are abnormal growths that develop in the brain or central nervous system. This track highlights advances in neuro-oncology, diagno
Track 20: Ovarian Cancer: **[Ovarian cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops in the ovaries, which are part of the female reproductive system and produce eggs and hormones suc
Track 21: Head and Neck Cancer: **[Head and neck cancer](https://cancer.ucgconferences.com/submit-abstract)** includes malignancies affecting the mouth, throat, larynx, nasal cavity, sinuses, and salivary glands. Most cases arise fr
Track 22: Pancreatic Cancer: **[Pancreatic cancer](https://cancer.ucgconferences.com/submit-abstract)** is a serious malignancy that often presents at an advanced stage, making early diagnosis and treatment challenging. This trac
Track 23: Liver cancer: **[Liver cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops in the liver and can significantly affect its essential functions, including metabolism, detoxificat
Track 24: Bone Cancer: **[Bone cancer](https://cancer.ucgconferences.com/submit-abstract)** is a malignancy that develops from abnormal cells within bone tissue and can form tumors that invade surrounding structures or spre
Track 25:Cancer Stem Cells: **[Cancer stem cells](https://cancer.ucgconferences.com/submit-abstract)** (CSCs) are a specialized population of tumor cells with self-renewal and differentiation capabilities. They are thought to co
Track 26:Cancer Biomarkers: **[Cancer biomarkers](https://cancer.ucgconferences.com/submit-abstract)** are measurable biological indicators found in blood, tissues, or other body fluids that can provide valuable information abou
Track 27: Precision Oncology: **[Precision oncology](https://cancer.ucgconferences.com/submit-abstract)** is an individualized approach to cancer care that uses genomic sequencing, molecular profiling, and biomarker analysis to id
Track 28: Cancer Prevention: **[Cancer prevention](https://cancer.ucgconferences.com/submit-abstract)** focuses on reducing the risk of cancer through proactive strategies that address modifiable risk factors, promote healthy beh
Track 29:Cancer Epidemiology: **[Cancer epidemiology](https://cancer.ucgconferences.com/submit-abstract)** examines the distribution, causes, risk factors, trends, and outcomes of cancer across populations. This track focuses on c
Track 30:Cancer Screening: **[Cancer screening](https://cancer.ucgconferences.com/submit-abstract)** involves the early identification of cancer or precancerous conditions in individuals who may not yet have symptoms. This trac

Programme

Mon 1 Feb 2027 — 08:00–08:30 — Registration Desk
Tue 2 Feb 2027 — 08:00–08:30 — Registration Desk
Tue 2 Feb 2027 — 08:30–09:00 — Opening Ceremony
Mon 1 Feb 2027 — 08:30–09:00 — Opening Ceremony
Tue 2 Feb 2027 — 09:00–10:00 — Keynote Introduction & Speech
Mon 1 Feb 2027 — 09:00–10:00 — Keynote Introduction & Speech
Tue 2 Feb 2027 — 10:00–10:30 — Speech & Poster Presentation
Mon 1 Feb 2027 — 10:00–10:30 — Speech & Poster Presentation
Tue 2 Feb 2027 — 10:30–10:45 — Coffee Break and Networking
Mon 1 Feb 2027 — 10:30–10:45 — Coffee Break and Networking
Mon 1 Feb 2027 — 10:45–11:30 — Exhibit Hall Open
Tue 2 Feb 2027 — 10:45–11:30 — Exhibit Hall Open
Tue 2 Feb 2027 — 11:30–13:00 — Speaker & Poster Presentations
Mon 1 Feb 2027 — 11:30–13:00 — Speaker & Poster Presentations
Tue 2 Feb 2027 — 13:00–13:10 — Professional Photography
Mon 1 Feb 2027 — 13:00–13:10 — Professional Photography
Tue 2 Feb 2027 — 13:10–14:00 — Lunch Break & Networking
Mon 1 Feb 2027 — 13:10–14:00 — Lunch Break & Networking
Tue 2 Feb 2027 — 16:00–16:15 — Coffee Break & Networking
Tue 2 Feb 2027 — 16:15–17:00 — Speech & Poster Presentation
Tue 2 Feb 2027 — 14:00–16:00 — Speaker & Poster Presentations
Tue 2 Feb 2027 — 17:00–17:30 — Panel Discussion
Mon 1 Feb 2027 — 14:00–16:00 — Speaker & Poster Presentations
Tue 2 Feb 2027 — 17:30–17:45 — Certificate Distribution
Mon 1 Feb 2027 — 16:00–16:15 — Coffee Break & Networking
Mon 1 Feb 2027 — 16:15–17:00 — Speech & Poster Presentation
Mon 1 Feb 2027 — 17:00–17:30 — Panel Discussion
Tue 2 Feb 2027 — 17:45–18:00 — Professional Photography
Mon 1 Feb 2027 — 17:30–17:45 — Certificate Distribution
Mon 1 Feb 2027 — 17:45–18:00 — Professional Photography
Tue 2 Feb 2027 — 18:00–18:30 — Closing Remarks
Mon 1 Feb 2027 — 18:00–18:30 — Closing Remarks

Registration

Abstract/Presentation/Poster Review Fee — USD 30
Abstract/Presentation/Poster Review Fee — USD 60
Speaker/Poster 1 Day Entry — USD 150
Speaker/Poster Package — USD 299
Speaker/Poster 1 Day Entry — USD 400
Speaker/Poster Package — USD 700
Delegate/Listener 1 Day Entry — USD 125
Delegate/Listener Package — USD 249
30 CME/CPD Credits — USD 250
Certificate(Mandatory) — USD 30
Package A(30 CME Credits) — USD 899
Package B(30 CME Credits) — USD 1099
Student Fee (ID card required) — USD 125
Visa Invitation Letter — USD 50
Delegate/Listener 1 Day Entry — USD 350
Delegate/Listener Package — USD 600
Group Pass(3 Attendees) — USD 1500
30 CME/CPD Credits — USD 600
Certificate(Mandatory) — USD 136
Package A(30 CME Credits) — USD 1798